Financials HBM Healthcare Investments AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:30 2024-04-26 am EDT			5-day change	1st Jan Change
188 ^CHF	0.00%		0.00%	+2.96%

Apr. 03	HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	MT
Jan. 22	HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Fiscal Period: Marzo	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	1,159	1,320	2,313	1,920	1,489	1,299	-	-
Enterprise Value (EV) ¹	1,159	1,320	2,409	2,064	1,632	1,267	1,246	1,224
P/E ratio	-	7.24 x	3.06 x	-24.6 x	-10.2 x	-18.2 x	77.7 x	12.8 x
Yield	4.44%	4.05%	3.76%	3.51%	3.5%	3.99%	2.99%	2.99%
Capitalization / Revenue	-	-	-	-51.2 x	-12.8 x	-30.6 x	28.2 x	9.92 x
EV / Revenue	-	-	-	-55 x	-14 x	-29.9 x	27 x	9.35 x
EV / EBITDA	-	7.13 x	3.18 x	-27.4 x	-11.2 x	-18 x	69.2 x	11.9 x
EV / FCF	-	-20.6 x	43.2 x	-34.3 x	18.3 x	667 x	20.1 x	19.8 x
FCF Yield	-	-4.86%	2.31%	-2.92%	5.46%	0.15%	4.97%	5.06%
Price to Book	0.89 x	1.01 x	1.08 x	0.97 x	0.84 x	0.79 x	0.8 x	0.77 x
Nbr of stocks (in thousands)	6,865	6,947	6,957	6,957	6,957	6,911	-	-
Reference price ²	168.8	190.0	332.5	276.0	214.0	188.0	188.0	188.0
Announcement Date	5/16/19	5/8/20	5/27/21	5/18/22	5/26/23	-	-	-

¹CHF in Million²CHF

Estimates

Fiscal Period: Marzo	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	-	-	-	-37.5	-116.5	-42.4	46.1	131
EBITDA ¹	-	185.1	758.7	-75.31	-146.1	-70.4	18	103
EBIT ¹	-	185.1	758.7	-75.31	-146.1	-70.4	18	103
Operating Margin	-	-	-	200.85%	125.35%	166.04%	39.05%	78.63%
Earnings before Tax (EBT) ¹	-	182.7	756.3	-78.03	-145.3	-71.7	18	103
Net income ¹	-	183	756.3	-78.03	-145.3	-71.7	18	103
Net margin	-	-	-	208.1%	124.67%	169.1%	39.05%	78.63%
EPS ²	-	26.26	108.7	-11.22	-20.98	-10.35	2.420	14.68
Free Cash Flow ¹	-	-64.16	55.77	-60.2	89.12	1.9	61.9	61.9
FCF margin	-	-	-	160.54%	-76.48%	-4.48%	134.27%	47.25%
FCF Conversion (EBITDA)	-	-	7.35%	-	-	-	343.89%	60.1%
FCF Conversion (Net income)	-	-	7.37%	-	-	-	343.89%	60.1%
Dividend per Share ²	7.500	7.700	12.50	9.700	7.500	7.500	5.620	5.620
Announcement Date	5/16/19	5/8/20	5/27/21	5/18/22	5/26/23	-	-	-

¹CHF in Million²CHF

Estimates

Fiscal Period: Marzo	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-	96.2	144	143	-	-	-
Net Cash position ¹	-	-	-	-	-	32	53	75
Leverage (Debt/EBITDA)	-	-	0.1268 x	-1.906 x	-0.982 x	-	-	-
Free Cash Flow ¹	-	-64.2	55.8	-60.2	89.1	1.9	61.9	61.9
ROE (net income / shareholders' equity)	-	-	-	-	-	-4.4%	-	-
ROA (Net income/ Total Assets)	-	-	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-	-	-
Book Value Per Share ²	189.0	188.0	309.0	286.0	255.0	237.0	234.0	243.0
Cash Flow per Share	-	-	-	-	-	-	-	-
Capex	-	-	-	-	-	-	-	-
Capex / Sales	-	-	-	-	-	-	-	-
Announcement Date	5/16/19	5/8/20	5/27/21	5/18/22	5/26/23	-	-	-

¹CHF in Million²CHF

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

D+

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

188 CHF

Average target price

236 CHF

Spread / Average Target

+25.53%

	1st Jan change	Capi.
HBM HEALTHCARE INVESTMENTS AG	+2.96%	1.42B
UMBRA COMPANIES INC.	+31.41%	12.02B
HERCULES CAPITAL, INC.	+14.40%	3.06B
OCTOPUS TITAN VCT PLC	-8.46%	1.22B
CION INVESTMENT CORPORATION	+1.15%	616M
MOLTEN VENTURES PLC	-10.84%	579M
VERUSA HOLDING	+35.79%	577M
OCTOPUS APOLLO VCT PLC	-4.17%	492M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+33.85%	488M
BRITISH SMALLER COMPANIES VCT PLC	+3.90%	304M